Exploring Barmah Forest virus pathogenesis: molecular tools to investigate non-structural protein 3 nuclear localization and viral genomic determinants of replication.

Barmah Forest virus alphavirus immune evasion nuclear transport reverse genetic analysis viral replication

Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
02 Jul 2024
Historique:
medline: 2 7 2024
pubmed: 2 7 2024
entrez: 2 7 2024
Statut: aheadofprint

Résumé

Barmah Forest virus (BFV) is a mosquito-borne virus that causes arthralgia with accompanying rash, fever, and myalgia in humans. The virus is mainly found in Australia and has caused outbreaks associated with significant health concerns. As the sole representative of the Barmah Forest complex within the genus

Identifiants

DOI: 10.1128/mbio.00993-24 PMID: 38953633
pubmed: 38953633
doi: 10.1128/mbio.00993-24
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0099324

Auteurs

Ailar Omler (A)

Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.
Institute of Bioengineering, University of Tartu, Tartu, Estonia.

Margit Mutso (M)

Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.
Institute of Technology, University of Tartu, Tartu, Estonia.

Mihkel Vaher (M)

The Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia.

Joseph R Freitas (JR)

Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.
Global Virus Network (GVN) Centre for Excellence in Arboviruses, Griffith University, Gold Coast, Queensland, Australia.
School of Pharmacy and Medical Sciences, Griffith University, Gold Coast, Queensland, Australia.

Adam Taylor (A)

Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.
Global Virus Network (GVN) Centre for Excellence in Arboviruses, Griffith University, Gold Coast, Queensland, Australia.
School of Pharmacy and Medical Sciences, Griffith University, Gold Coast, Queensland, Australia.
ORCID: 0000-0002-7159-3961

Cassandra T David (CT)

Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.

Gregory W Moseley (GW)

Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
ORCID: 0000-0003-4516-3906

Xiang Liu (X)

Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.
Global Virus Network (GVN) Centre for Excellence in Arboviruses, Griffith University, Gold Coast, Queensland, Australia.
School of Pharmacy and Medical Sciences, Griffith University, Gold Coast, Queensland, Australia.
ORCID: 0000-0002-8165-3294

Andres Merits (A)

Institute of Bioengineering, University of Tartu, Tartu, Estonia.
ORCID: 0000-0001-8193-0071

Suresh Mahalingam (S)

Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.
Global Virus Network (GVN) Centre for Excellence in Arboviruses, Griffith University, Gold Coast, Queensland, Australia.
School of Pharmacy and Medical Sciences, Griffith University, Gold Coast, Queensland, Australia.
ORCID: 0000-0003-3141-8410

Classifications MeSH